Skip to main content
Premium Trial:

Request an Annual Quote

Caribou Biosciences: Syed Rizvi

Syed Rizvi has been appointed as chief medical officer of Caribou Biosciences, a new position at the company. Most recently, he served in the same role at Chimeric Therapeutics, and before that, he held various roles, including head and VP of clinical development, at Legend Biotech. Previously, he was head of global medical affairs for CAR-T cell programs and head of hematology and immuno-oncology for US medical affairs at Celgene. Rizvi holds a medical degree from Dow Medical College.

The Scan

Denisovan Girl's Tooth Found in Laos

CNN reports that a tooth found in a cave north of Vientiane likely belonged to a Denisovan girl.

A Lack of Diversity in Trials

A new report from the National Academies of Science, Engineering, and Medicine examines the limited representation of diverse groups among clinical trial participants.

Another Look

A new inquiry is to be held after genetic evidence indicates that Kathleen Folbigg's children may have been at increased risk of sudden death, the Sydney Morning Herald reports.

Nucleic Acids Research Studies on ICARUS, Neighbor-seq, CADDIE

In Nucleic Acids Research this week: resource to analyze and visualize single-cell RNA-seq data, method to examine cellular interactions, and more.